Medical and economic outcomes of point-of-care testing

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 3, 2002, Pages 246-251

  Price, Christopher P ^a  

^a Bayer Diagnostics Europe   (United Kingdom)

Author keywords

Clinical and economic outcomes; Compliance with therapy; Cost benefit; Point of care testing; Surrogate markers

Indexed keywords

ALBUMIN; ANTICONVULSIVE AGENT; HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD CLOTTING; BONE DENSITY; BONE MINERAL; CHRONIC DISEASE; CRISIS INTERVENTION; DIABETES MELLITUS; DIET THERAPY; ECONOMIC ASPECT; EPILEPSY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HOSPITAL INFORMATION SYSTEM; HUMAN; LENGTH OF STAY; MEDICAL DECISION MAKING; MICROALBUMINURIA; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SATISFACTION; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

BLOOD CHEMICAL ANALYSIS; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; HUMANS; LABORATORIES; OUTCOME ASSESSMENT (HEALTH CARE); POINT-OF-CARE SYSTEMS; QUALITY CONTROL; TREATMENT OUTCOME;

EID: 0036237357     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.040     Document Type: Article

References (49)

1. Evidence-based laboratory medicine: Supporting decision-making
2. Point-of-care testing
3. Informatics in point-of-care testing
4. Guidelines on point-of-care testing
5. Guidelines for near-patient testing: Haematology
6. Guidelines for implementation of near patient testing
7. Clinical outcomes of point-of-care testing in the interventional radiology and invasive cardiology setting
8. Use of computer terminals on wards to access emergency test results: A retrospective audit
9. Point of care testing: Randomised, controlled trial of clinical outcome
10. Point-of-care testing: Impact on medical outcomes
11. Scientific basis of health services
12. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
13. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
14. Education and home glucose monitoring
15. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes Registry
16. 1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients
17. Near patient-testing in diabetes clinics: Appraising the costs and outcomes
18. Diabetes care in general practice: Meta-analysis of randomised control trials
19. Intensified versus conventional management of gestational diabetes
20. Pregnancy and diabetes mellitus
21. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside randomised controlled trial (UKPDS 41)
22. Effect of improved glycemic control on health care costs and utilization
23. Immediate anticonvulsive drug monitoring in management of epilepsy
24. The impact of near patient testing on the organization and costs of an anticonvulsant clinic
25. Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic
26. A randomised controlled trial comparing primary care oral anticoagulant management utilising computerised decision support (DSS) and near patient testing (NPT) with traditional management
27. A structured teaching and self-management program for patients receiving oral anticoagulation
28. Point-of-care testing in the intensive care unit
29. Evaluation of a portable clinical blood analyzer in the emergency department
30. Point-of-care versus central laboratory testing: An economic analysis in an academic medical center
31. Impact of point-of-care testing on patients' length of stay in a large emergency department
32. The need for a point of care testing: An evidence-based appraisal
33. Cardiac markers: Point of care testing
34. Strategies for the early diagnosis of acute myocardial infarction using biochemical markers
35. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
36. Diagnostic cohort study of an emergency department based 6 hour rule-out protocol for myocardial damage
37. Impact of troponin T determinations of hospital resource utilization and costs in the evaluation of patients with suspected myocardial ischemia
38. Perioperative laboratory support
39. The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective, randomized evaluation in patients undergoing cardiac operations
40. Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: A coronary care unit experience
41. Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay
42. Outpatient minimally invasive parathyroidectomy: A combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay
43. Impact of introducing near patient testing for standard investigations in general practice
44. Implications of probability analysis for interpreting results of leukocyte esterase and nitrite
45. The diagnostic accuracy of rapid dipstick tests to predict urinary tract infection
46. A review of near patient testing in primary care
47. Measurement of C-reactive protein and the erythrocyte sedimentation rate in general practice
48. Near-patient test for C-reactive protein in general practice: Assessment of clinical, organisational, and economic outcomes